Showing results (491-500 of 585) with videos related to

Sort By:
Pageof 59
Gastroenterology|August 7, 2012
Lymphotoxin β receptor signaling promotes development of autoimmune pancreatitisGitta M Seleznik, Theresia Reding, Franziska Romrig, et al.
Cytokine|August 30, 2024
Case-control study of IL23R rs76418789 polymorphism, smoking, and ulcerative colitis in JapanYoshihiro Miyake, Keiko Tanaka, Chisato Nagata, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 15, 2021
Dietary intake of vegetables, fruit, and antioxidants and risk of ulcerative colitis: A case-control study in JapanYoshihiro Miyake, Keiko Tanaka, Chisato Nagata, et al.
Scientific Reports|July 15, 2021
Impact of modified albumin-bilirubin grade on survival in patients with HCC who received lenvatinibToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Journal of Gastroenterology and Hepatology|December 11, 2023
Coffee and caffeine intake reduces risk of ulcerative colitis: a case-control study in JapanKeiko Tanaka, Hitomi Okubo, Yoshihiro Miyake, et al.
Journal of Gastroenterology and Hepatology|November 10, 2020
Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weightingAtsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, et al.
Cancer Reports (Hoboken, N.J.)|June 11, 2021
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experienceAtsushi Hiraoka, Takashi Kumada, Toshifumi Tada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 29, 2025
Human Leukocyte Antigen Genotypes Affect Hepatitis B Virus Mutations Associated With Hepatocellular CarcinomaMasaya Sugiyama, Nao Nishida, Seik-Soon Khor, et al.
European Journal of Gastroenterology & Hepatology|July 8, 2022
Glasgow prognostic score predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib: a multicenter analysisToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Pageof 59